ID   HSC20_HUMAN             Reviewed;         235 AA.
AC   Q8IWL3; Q9BWS7;
DT   29-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2005, sequence version 3.
DT   18-JUN-2025, entry version 174.
DE   RecName: Full=Iron-sulfur cluster co-chaperone protein HscB {ECO:0000305};
DE   AltName: Full=DnaJ homolog subfamily C member 20;
DE   Contains:
DE     RecName: Full=Iron-sulfur cluster co-chaperone protein HscB, cytoplasmic;
DE              Short=C-HSC20 {ECO:0000303|PubMed:29309586};
DE   Contains:
DE     RecName: Full=Iron-sulfur cluster co-chaperone protein HscB, mitochondrial;
GN   Name=HSCB {ECO:0000312|HGNC:HGNC:28913}; Synonyms=DNAJC20, HSC20;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=12938016; DOI=10.1007/s10038-003-0048-9;
RA   Sun G., Gargus J.J., Ta D.T., Vickery L.E.;
RT   "Identification of a novel candidate gene in the iron-sulfur pathway
RT   implicated in ataxia-susceptibility: human gene encoding HscB, a J-type co-
RT   chaperone.";
RL   J. Hum. Genet. 48:415-419(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M.,
RA   Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C.,
RA   Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E.,
RA   Bridgeman A.M., Buck D., Burgess J., Burrill W.D., Burton J., Carder C.,
RA   Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G.,
RA   Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V.,
RA   Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M.,
RA   Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E.,
RA   Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F.,
RA   Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M.,
RA   Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A.,
RA   Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D.,
RA   Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y.,
RA   Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S.,
RA   Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E.,
RA   Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A.,
RA   Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L.,
RA   Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P.,
RA   Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P.,
RA   Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q.,
RA   Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J.,
RA   Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J.,
RA   Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D.,
RA   Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T.,
RA   Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P.,
RA   Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K.,
RA   Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L.,
RA   McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J.,
RA   Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E.,
RA   Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P.,
RA   Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y.,
RA   Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, INTERACTION WITH ISCU AND HSPA9, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND MUTAGENESIS OF CYS-41; CYS-44; CYS-58; CYS-61 AND
RP   102-HIS--ASP-104.
RX   PubMed=20668094; DOI=10.1093/hmg/ddq301;
RA   Uhrigshardt H., Singh A., Kovtunovych G., Ghosh M., Rouault T.A.;
RT   "Characterization of the human HSC20, an unusual DnaJ type III protein,
RT   involved in iron-sulfur cluster biogenesis.";
RL   Hum. Mol. Genet. 19:3816-3834(2010).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH SDHAF1.
RX   PubMed=26749241; DOI=10.1016/j.cmet.2015.12.005;
RA   Maio N., Ghezzi D., Verrigni D., Rizza T., Bertini E., Martinelli D.,
RA   Zeviani M., Singh A., Carrozzo R., Rouault T.A.;
RT   "Disease-causing SDHAF1 mutations impair transfer of Fe-S clusters to
RT   SDHB.";
RL   Cell Metab. 23:292-302(2016).
RN   [8]
RP   FUNCTION, SUBUNIT, INTERACTION WITH CIAO1 AND ISCU, SUBCELLULAR LOCATION,
RP   MUTAGENESIS OF CYS-41; CYS-44; CYS-58 AND CYS-61, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=29309586; DOI=10.1093/hmg/ddy004;
RA   Kim K.S., Maio N., Singh A., Rouault T.A.;
RT   "Cytosolic HSC20 integrates de novo iron-sulfur cluster biogenesis with the
RT   CIAO1-mediated transfer to recipients.";
RL   Hum. Mol. Genet. 27:837-852(2018).
RN   [9]
RP   INVOLVEMENT IN SIDBA5.
RX   PubMed=32634119; DOI=10.1172/jci135479;
RA   Crispin A., Guo C., Chen C., Campagna D.R., Schmidt P.J., Lichtenstein D.,
RA   Cao C., Sendamarai A.K., Hildick-Smith G.J., Huston N.C., Boudreaux J.,
RA   Bottomley S.S., Heeney M.M., Paw B.H., Fleming M.D., Ducamp S.;
RT   "Mutations in the iron-sulfur cluster biogenesis protein HSCB cause
RT   congenital sideroblastic anemia.";
RL   J. Clin. Invest. 130:5245-5256(2020).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 30-235, AND METAL-BINDING SITES.
RX   PubMed=18713742; DOI=10.1074/jbc.m804746200;
RA   Bitto E., Bingman C.A., Bittova L., Kondrashov D.A., Bannen R.M., Fox B.G.,
RA   Markley J.L., Phillips G.N. Jr.;
RT   "Structure of human J-type co-chaperone HscB reveals a tetracysteine metal-
RT   binding domain.";
RL   J. Biol. Chem. 283:30184-30192(2008).
CC   -!- FUNCTION: [Iron-sulfur cluster co-chaperone protein HscB,
CC       mitochondrial]: Acts as a co-chaperone in iron-sulfur cluster assembly
CC       in mitochondria (PubMed:20668094). Required for incorporation of iron-
CC       sulfur clusters into SDHB, the iron-sulfur protein subunit of succinate
CC       dehydrogenase that is involved in complex II of the mitochondrial
CC       electron transport chain (PubMed:26749241). Recruited to SDHB by
CC       interaction with SDHAF1 which first binds SDHB and then recruits the
CC       iron-sulfur transfer complex formed by HSC20, HSPA9 and ISCU through
CC       direct binding to HSC20 (PubMed:26749241). Plays an essential role in
CC       hematopoiesis (By similarity). {ECO:0000250|UniProtKB:Q8K3A0,
CC       ECO:0000269|PubMed:20668094, ECO:0000269|PubMed:26749241}.
CC   -!- FUNCTION: [Iron-sulfur cluster co-chaperone protein HscB, cytoplasmic]:
CC       Acts as a co-chaperone in iron-sulfur cluster assembly in the cytoplasm
CC       (PubMed:29309586). Also mediates complex formation between components
CC       of the cytosolic iron-sulfur biogenesis pathway and the CIA targeting
CC       complex composed of CIAO1, DIPK1B/FAM69B and MMS19 by binding directly
CC       to the scaffold protein ISCU and to CIAO1 (PubMed:29309586). This
CC       facilitates iron-sulfur cluster insertion into a number of cytoplasmic
CC       and nuclear proteins including POLD1, ELP3, DPYD and PPAT
CC       (PubMed:29309586). {ECO:0000269|PubMed:29309586}.
CC   -!- PATHWAY: Cofactor biosynthesis; iron-sulfur cluster biosynthesis.
CC   -!- SUBUNIT: [Iron-sulfur cluster co-chaperone protein HscB,
CC       mitochondrial]: Interacts with ISCU and HSPA9 to form an iron-sulfur
CC       transfer complex (PubMed:20668094). Interacts with SDHAF1 (via the
CC       first LYR motif); the interaction recruits the iron-sulfur transfer
CC       complex composed of HSC20, HSPA9 and ISCU and mediates the
CC       incorporation of iron-sulfur clusters into SDHB which also interacts
CC       with HSC20 (PubMed:26749241). Interacts with the cytoplasmic form of
CC       ISCU and with CIA complex member CIAO1 (via LYR motif)
CC       (PubMed:29309586). {ECO:0000269|PubMed:20668094,
CC       ECO:0000269|PubMed:26749241}.
CC   -!- SUBUNIT: [Iron-sulfur cluster co-chaperone protein HscB, cytoplasmic]:
CC       Homodimer (PubMed:29309586). Interacts with ISCU (cytoplasmic form);
CC       this interaction stabilizes the (Fe-S) clusters on ISCU
CC       (PubMed:29309586). Interacts with the CIA complex member CIAO1 (via LYR
CC       motif) (PubMed:29309586). {ECO:0000269|PubMed:29309586}.
CC   -!- INTERACTION:
CC       Q8IWL3; Q6RW13: AGTRAP; NbExp=4; IntAct=EBI-1805738, EBI-741181;
CC       Q8IWL3; P07814: EPRS1; NbExp=4; IntAct=EBI-1805738, EBI-355315;
CC       Q8IWL3; P13804: ETFA; NbExp=3; IntAct=EBI-1805738, EBI-1052886;
CC       Q8IWL3; Q86SX6: GLRX5; NbExp=3; IntAct=EBI-1805738, EBI-1049910;
CC       Q8IWL3; P42694: HELZ; NbExp=4; IntAct=EBI-1805738, EBI-1210654;
CC       Q8IWL3; Q8IWL3: HSCB; NbExp=3; IntAct=EBI-1805738, EBI-1805738;
CC       Q8IWL3; P38646: HSPA9; NbExp=14; IntAct=EBI-1805738, EBI-354932;
CC       Q8IWL3; Q5U5X0: LYRM7; NbExp=7; IntAct=EBI-1805738, EBI-13943106;
CC       Q8IWL3; P19404: NDUFV2; NbExp=6; IntAct=EBI-1805738, EBI-713665;
CC       Q8IWL3; P16083: NQO2; NbExp=4; IntAct=EBI-1805738, EBI-358466;
CC       Q8IWL3; A6NFY7: SDHAF1; NbExp=5; IntAct=EBI-1805738, EBI-12011488;
CC       Q8IWL3; P21912: SDHB; NbExp=22; IntAct=EBI-1805738, EBI-1056481;
CC       Q8IWL3; Q96I99: SUCLG2; NbExp=4; IntAct=EBI-1805738, EBI-2511878;
CC   -!- SUBCELLULAR LOCATION: [Iron-sulfur cluster co-chaperone protein HscB,
CC       cytoplasmic]: Cytoplasm {ECO:0000269|PubMed:20668094,
CC       ECO:0000269|PubMed:29309586}.
CC   -!- SUBCELLULAR LOCATION: [Iron-sulfur cluster co-chaperone protein HscB,
CC       mitochondrial]: Mitochondrion {ECO:0000269|PubMed:20668094}.
CC   -!- TISSUE SPECIFICITY: Expressed in lung, brain, stomach, spleen, ovary,
CC       testis, liver, muscle and heart. {ECO:0000269|PubMed:12938016,
CC       ECO:0000269|PubMed:20668094}.
CC   -!- DISEASE: Anemia, sideroblastic, 5 (SIDBA5) [MIM:619523]: A form of
CC       sideroblastic anemia, a bone marrow disorder defined by the presence of
CC       pathologic iron deposits in erythroblast mitochondria. Sideroblastic
CC       anemia is characterized by anemia of varying severity, hypochromic
CC       peripheral erythrocytes, systemic iron overload secondary to chronic
CC       ineffective erythropoiesis, and the presence of bone marrow ringed
CC       sideroblasts. Sideroblasts are characterized by iron-loaded
CC       mitochondria clustered around the nucleus. SIDBA5 inheritance is
CC       autosomal recessive. {ECO:0000269|PubMed:32634119}. Note=The disease is
CC       caused by variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the HscB family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY191719; AAN85282.1; -; mRNA.
DR   EMBL; CR456462; CAG30348.1; -; mRNA.
DR   EMBL; AL023494; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL117330; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC065569; AAH65569.1; -; mRNA.
DR   CCDS; CCDS13845.1; -.
DR   RefSeq; NP_741999.3; NM_172002.4.
DR   PDB; 3BVO; X-ray; 3.00 A; A/B=30-235.
DR   PDBsum; 3BVO; -.
DR   AlphaFoldDB; Q8IWL3; -.
DR   SASBDB; Q8IWL3; -.
DR   SMR; Q8IWL3; -.
DR   BioGRID; 127276; 818.
DR   DIP; DIP-46570N; -.
DR   FunCoup; Q8IWL3; 2183.
DR   IntAct; Q8IWL3; 736.
DR   STRING; 9606.ENSP00000216027; -.
DR   iPTMnet; Q8IWL3; -.
DR   PhosphoSitePlus; Q8IWL3; -.
DR   BioMuta; HSCB; -.
DR   DMDM; 60416441; -.
DR   jPOST; Q8IWL3; -.
DR   MassIVE; Q8IWL3; -.
DR   PaxDb; 9606-ENSP00000216027; -.
DR   PeptideAtlas; Q8IWL3; -.
DR   ProteomicsDB; 70870; -.
DR   Pumba; Q8IWL3; -.
DR   Antibodypedia; 10209; 130 antibodies from 21 providers.
DR   DNASU; 150274; -.
DR   Ensembl; ENST00000216027.8; ENSP00000216027.3; ENSG00000100209.11.
DR   GeneID; 150274; -.
DR   KEGG; hsa:150274; -.
DR   MANE-Select; ENST00000216027.8; ENSP00000216027.3; NM_172002.5; NP_741999.3.
DR   UCSC; uc003aea.4; human.
DR   AGR; HGNC:28913; -.
DR   CTD; 150274; -.
DR   DisGeNET; 150274; -.
DR   GeneCards; HSCB; -.
DR   HGNC; HGNC:28913; HSCB.
DR   HPA; ENSG00000100209; Low tissue specificity.
DR   MalaCards; HSCB; -.
DR   MIM; 608142; gene.
DR   MIM; 619523; phenotype.
DR   OpenTargets; ENSG00000100209; -.
DR   VEuPathDB; HostDB:ENSG00000100209; -.
DR   eggNOG; KOG3192; Eukaryota.
DR   GeneTree; ENSGT00390000008206; -.
DR   HOGENOM; CLU_068529_0_2_1; -.
DR   InParanoid; Q8IWL3; -.
DR   OMA; LMFIERF; -.
DR   OrthoDB; 448954at2759; -.
DR   PAN-GO; Q8IWL3; 2 GO annotations based on evolutionary models.
DR   PhylomeDB; Q8IWL3; -.
DR   PathwayCommons; Q8IWL3; -.
DR   Reactome; R-HSA-1268020; Mitochondrial protein import.
DR   Reactome; R-HSA-1362409; Mitochondrial iron-sulfur cluster biogenesis.
DR   Reactome; R-HSA-6799198; Complex I biogenesis.
DR   Reactome; R-HSA-9865881; Complex III assembly.
DR   SignaLink; Q8IWL3; -.
DR   SIGNOR; Q8IWL3; -.
DR   UniPathway; UPA00266; -.
DR   BioGRID-ORCS; 150274; 602 hits in 1177 CRISPR screens.
DR   ChiTaRS; HSCB; human.
DR   EvolutionaryTrace; Q8IWL3; -.
DR   GenomeRNAi; 150274; -.
DR   Pharos; Q8IWL3; Tbio.
DR   PRO; PR:Q8IWL3; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; Q8IWL3; protein.
DR   Bgee; ENSG00000100209; Expressed in parotid gland and 187 other cell types or tissues.
DR   ExpressionAtlas; Q8IWL3; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0001671; F:ATPase activator activity; IEA:InterPro.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0051087; F:protein-folding chaperone binding; IEA:InterPro.
DR   GO; GO:0044571; P:[2Fe-2S] cluster assembly; IBA:GO_Central.
DR   GO; GO:0016226; P:iron-sulfur cluster assembly; IMP:UniProtKB.
DR   GO; GO:0060319; P:primitive erythrocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0060215; P:primitive hemopoiesis; ISS:UniProtKB.
DR   GO; GO:0051259; P:protein complex oligomerization; IEA:InterPro.
DR   FunFam; 1.20.1280.20:FF:000002; HscB mitochondrial iron-sulfur cluster co-chaperone; 1.
DR   FunFam; 1.10.287.110:FF:000042; Iron-sulfur cluster co-chaperone protein HscB, mitochondrial; 1.
DR   Gene3D; 1.10.287.110; DnaJ domain; 1.
DR   Gene3D; 1.20.1280.20; HscB, C-terminal domain; 1.
DR   HAMAP; MF_00682; HscB; 1.
DR   InterPro; IPR004640; HscB.
DR   InterPro; IPR040682; HscB_4_cys.
DR   InterPro; IPR036386; HscB_C_sf.
DR   InterPro; IPR009073; HscB_oligo_C.
DR   InterPro; IPR036869; J_dom_sf.
DR   NCBIfam; TIGR00714; hscB; 1.
DR   PANTHER; PTHR14021; IRON-SULFUR CLUSTER CO-CHAPERONE PROTEIN HSCB; 1.
DR   PANTHER; PTHR14021:SF15; IRON-SULFUR CLUSTER CO-CHAPERONE PROTEIN HSCB; 1.
DR   Pfam; PF18256; HscB_4_cys; 1.
DR   Pfam; PF07743; HSCB_C; 1.
DR   SUPFAM; SSF46565; Chaperone J-domain; 1.
DR   SUPFAM; SSF47144; HSC20 (HSCB), C-terminal oligomerisation domain; 1.
DR   neXtProt; NX_Q8IWL3; -.
DR   PharmGKB; PA162391621; -.
DR   TreeFam; TF319992; -.
PE   1: Evidence at protein level;
KW   3D-structure; Chaperone; Cytoplasm; Metal-binding; Mitochondrion;
KW   Proteomics identification; Reference proteome.
FT   CHAIN           1..235
FT                   /note="Iron-sulfur cluster co-chaperone protein HscB,
FT                   cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:29309586"
FT                   /id="PRO_0000446242"
FT   CHAIN           30..235
FT                   /note="Iron-sulfur cluster co-chaperone protein HscB,
FT                   mitochondrial"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000007262"
FT   DOMAIN          72..144
FT                   /note="J"
FT   BINDING         41
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /evidence="ECO:0000269|PubMed:18713742,
FT                   ECO:0007744|PDB:3BVO"
FT   BINDING         44
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /evidence="ECO:0000269|PubMed:18713742,
FT                   ECO:0007744|PDB:3BVO"
FT   BINDING         58
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /evidence="ECO:0000269|PubMed:18713742,
FT                   ECO:0007744|PDB:3BVO"
FT   BINDING         61
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /evidence="ECO:0000269|PubMed:18713742,
FT                   ECO:0007744|PDB:3BVO"
FT   VARIANT         73
FT                   /note="Y -> C (in dbSNP:rs17886090)"
FT                   /id="VAR_048916"
FT   VARIANT         163
FT                   /note="I -> M (in dbSNP:rs17884212)"
FT                   /id="VAR_048917"
FT   MUTAGEN         41
FT                   /note="C->S: Abolishes self-interaction and interaction
FT                   with HSPA9 and the CIA complex but does not alter
FT                   subcellular localization; when associated with S-44; S-58
FT                   and S-61."
FT                   /evidence="ECO:0000269|PubMed:20668094,
FT                   ECO:0000269|PubMed:29309586"
FT   MUTAGEN         44
FT                   /note="C->S: Abolishes self-interaction and interaction
FT                   with HSPA9 and the CIA complex but does not alter
FT                   subcellular localization; when associated with S-41; S-58
FT                   and S-61."
FT                   /evidence="ECO:0000269|PubMed:20668094,
FT                   ECO:0000269|PubMed:29309586"
FT   MUTAGEN         58
FT                   /note="C->S: Abolishes self-interaction and interaction
FT                   with HSPA9 and the CIA complex but does not alter
FT                   subcellular localization; when associated with S-41; S-44
FT                   and S-61."
FT                   /evidence="ECO:0000269|PubMed:20668094,
FT                   ECO:0000269|PubMed:29309586"
FT   MUTAGEN         61
FT                   /note="C->S: Abolishes self-interaction and interaction
FT                   with HSPA9 and the CIA complex but does not alter
FT                   subcellular localization; when associated with S-41; S-44
FT                   and S-58."
FT                   /evidence="ECO:0000269|PubMed:20668094,
FT                   ECO:0000269|PubMed:29309586"
FT   MUTAGEN         102..104
FT                   /note="HPD->AAA: Does not interact with HSPA9. Does not
FT                   inhibit interaction with ISCU."
FT                   /evidence="ECO:0000269|PubMed:20668094"
FT   CONFLICT        43
FT                   /note="N -> S (in Ref. 1; AAN85282)"
FT                   /evidence="ECO:0000305"
FT   STRAND          42..44
FT                   /evidence="ECO:0007829|PDB:3BVO"
FT   TURN            59..61
FT                   /evidence="ECO:0007829|PDB:3BVO"
FT   HELIX           73..76
FT                   /evidence="ECO:0007829|PDB:3BVO"
FT   HELIX           87..101
FT                   /evidence="ECO:0007829|PDB:3BVO"
FT   HELIX           103..106
FT                   /evidence="ECO:0007829|PDB:3BVO"
FT   HELIX           111..132
FT                   /evidence="ECO:0007829|PDB:3BVO"
FT   HELIX           134..144
FT                   /evidence="ECO:0007829|PDB:3BVO"
FT   STRAND          154..157
FT                   /evidence="ECO:0007829|PDB:3BVO"
FT   HELIX           159..174
FT                   /evidence="ECO:0007829|PDB:3BVO"
FT   HELIX           178..204
FT                   /evidence="ECO:0007829|PDB:3BVO"
FT   HELIX           208..231
FT                   /evidence="ECO:0007829|PDB:3BVO"
FT   TURN            232..234
FT                   /evidence="ECO:0007829|PDB:3BVO"
SQ   SEQUENCE   235 AA;  27422 MW;  70CF499E58FFD1C2 CRC64;
     MWRGRAGALL RVWGFWPTGV PRRRPLSCDA ASQAGSNYPR CWNCGGPWGP GREDRFFCPQ
     CRALQAPDPT RDYFSLMDCN RSFRVDTAKL QHRYQQLQRL VHPDFFSQRS QTEKDFSEKH
     STLVNDAYKT LLAPLSRGLY LLKLHGIEIP ERTDYEMDRQ FLIEIMEINE KLAEAESEAA
     MKEIESIVKA KQKEFTDNVS SAFEQDDFEE AKEILTKMRY FSNIEEKIKL KKIPL
//
